ACVRL1 (Activin A Receptor Like Type 1)

Key regulator of angiogenesis and vascular development; mutations cause hereditary hemorrhagic telangiectasia type 2 (HHT2).

Gene Information Card

Symbol ACVRL1
Full Name Activin A Receptor Like Type 1
Gene Type Protein coding
Chromosomal Location 12q13.13
NCBI Gene ID 94 ncbi.nlm.nih.gov/gene/94
Ensembl ID ENSG00000139567
UniProt ID P37023
OMIM ID 601284
HGNC ID 175
Aliases ALK1, HHT2, ACVRLK1, TSR-I

Description

The ACVRL1 gene encodes activin A receptor like type 1 (ALK1), a type I receptor in the TGF-beta superfamily. ALK1 is predominantly expressed on endothelial cells and plays a critical role in angiogenesis by transducing signals from BMP9 and BMP10 ligands. Mutations in ACVRL1 cause hereditary hemorrhagic telangiectasia type 2 (HHT2), an autosomal dominant disorder characterized by vascular malformations, epistaxis, and telangiectasias.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hereditary hemorrhagic telangiectasia type 2 (HHT2) Loss-of-function mutations in ACVRL1 impair BMP9/BMP10 signaling, leading to abnormal angiogenesis and fragile blood vessels. OMIM #601284; ClinVar; multiple peer-reviewed studies
Pulmonary arterial hypertension (PAH) Rare missense variants in ACVRL1 disrupt endothelial BMP signaling, contributing to vascular remodeling. ClinVar; NCBI GeneReviews

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 12.5 Medium
Heart 8.3 Low
Liver 6.7 Low
Brain 2.1 Not detected
Kidney 4.5 Low
Cell Line Expression
Cell Line nTPM Notes
HUVEC (umbilical vein endothelial) 35.2 High expression; primary endothelial model
HPAEC (pulmonary artery endothelial) 28.9 High expression
HEK293 1.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1120C>T (p.Arg374Trp) Missense Common in HHT2 Loss of receptor function; impaired BMP9 binding
c.1231C>T (p.Arg411Trp) Missense Recurrent Dominant-negative effect; reduced cell surface expression
c.1450C>T (p.Arg484Ter) Nonsense Rare Premature truncation; complete loss of kinase domain
Mutation functional classification

Loss of Function (LOF)

Most HHT2-associated mutations (nonsense, frameshift, splice-site) lead to haploinsufficiency or complete loss of ALK1 function.

Gain of Function (GOF)

Not reported for ACVRL1; gain-of-function mutations are not associated with HHT2.

Dominant Negative (DN)

Some missense mutations (e.g., p.Arg411Trp) produce a receptor that interferes with wild-type ALK1 signaling.

Gene Ontology (GO)

• GO:0004672 (protein kinase activity) • GO:0005024 (transforming growth factor beta receptor activity
• type I) • GO:0007179 (transforming growth factor beta receptor signaling pathway)
• GO:0001525 (angiogenesis) • GO:0016021 (integral component of membrane)

Pathways

TGF-beta signaling pathway (KEGG: hsa04350)
BMP signaling pathway (Reactome: R-HSA-201451)
Signaling by TGF-beta family members (Reactome: R-HSA-9006936)

Protein Summary

ALK1 is a 503-amino acid transmembrane serine/threonine kinase receptor. It consists of an extracellular ligand-binding domain, a single transmembrane helix, and an intracellular kinase domain. Upon binding BMP9 or BMP10, ALK1 phosphorylates SMAD1/5/8, which then complex with SMAD4 to regulate transcription of angiogenic genes. ALK1 is essential for endothelial cell proliferation, migration, and vessel maturation.

Related Products

Product name Cat.No. Species Gene ID
ACVRL1 Knockout HEK293 Cell Line EDJ-KQ17795 Human 94 Details Get a Quote
ACVRL1 Knockout HeLa Cell Line EDJ-KQ52544 Human 94 Details Get a Quote
ACVRL1 Knockout A-549 Cell Line EDJ-KQ61028 Human 94 Details Get a Quote
ACVRL1 Knockout HCT 116 Cell Line EDJ-KQ69503 Human 94 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: